Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December.
The item "Price-To-Sales-Ratio" stands at 13.05 as of 06/30/2025, the highest value at least since 12/31/2023, the period currently displayed.
As of the end of Hansoh Pharmaceutical Group Co Ltd's second quarter, the item "Price To Sales Ratio" stands at 13.05. This represents an increase of 11.78 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 51.01 percent compared to the value the year prior.
The 1 year change in percent is 51.01.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Price To Sales Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Price To Sales Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Price To Sales Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Price To Sales Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Price To Sales Ratio | 280,205,508,085.11 |